RoyMunson69
Posted - 3 hours ago
$SPRY Another red day nice
Arroin
Posted - 3 days ago
@bobbyhughes611 Thank you for your input. I really have no clue as to what initiates a BO, but I do know $SPRY and $AQST have unique products. But I figured maybe being in competition with each other would cut potential profits for both.
S_Franconi
Posted - 3 days ago
@Marcus02 @Arrointhere I hope it will be. I'm concerned about $AQST lack of cash, it's such an outlier, but I can't imagine anyone wanting to carry a pen or spray when they can carry a tiny film. Hope I'm not wrong. Certainly $SPRY has received a lot of backing (And I think is being marketed to children and parents with a cute little name), and $AQST has some that is foreign to me for the most part.
Arroin
Posted - 4 days ago
$AKBA $AQST I have been thinking about BO possibilities for each of these. My thoughts are that AKBA is more likely to be BO because it has less competition for it’s product , is more affordable, and is focused more in one area.
AKBA has more variety of products and it does have competition by $SPRY. Would love to hear opinions on this, or what the actual possibility of a BO is.
RoyMunson69
Posted - 5 days ago
$SPRY Another red day nice
Quantumup
Posted - 6 days ago
H.C. Wainwright reiterated $AQST Buy; $10, after the Co announced that the FDA had granted seven years of Orphan Drug exclusivity (ODE) to Libervant (diazepam) buccal film—The FDA granted ODE to Libervant in this population based on the assessment that Libervant's buccal route of administration provides a major contribution to patient care over the rectal route of administration by providing a significantly improved ease of use. $SPRY H.C. Wainwright said in it research report:
Thestocktraderhubzee
Posted - 6 days ago
WATCHLIST DEC 20 2024
$GSK GSK Announced Headline Results From FIRST-ENGOT-OV44 Phase 3 Trial Of Zejula (Niraparib) And Jemperli (Dostarlimab) In First Line Advanced Ovarian Cancer, The Trial Met Its Primary Endpoint Of Progression-free Survival, The Key Secondary Endpoint Of Overall Survival Did Not Meet Statistical Significance
$IONS Ionis Pharmaceuticals' TRYNGOLZA (olezarsen) Becomes First FDA-Approved Treatment For Adults with Familial Chylomicronemia Syndrome
$MRK BMO Capital Downgrades Merck & Co to Market Perform, Lowers Price Target to $105
$SPRY ARS Pharmaceuticals Says Express Scripts Has Added neffy (Epinephrine Nasal Spray) To Its Commercial National Formularies
$GIS Citigroup Maintains Neutral on General Mills, Lowers Price Target to $67
BioEmerging
Posted - 6 days ago
$SPRY express scripts! That’s the kind of announcement we need!
RoyMunson69
Posted - 1 week ago
$SPRY The problem is their launch sucks. They aren’t going to meet estimates
Mattbean
Posted - 1 week ago
$SPRY thank you :)
RoyMunson69
Posted - 1 week ago
$SPRY That makes no sense but congrats
BlackMyth
Posted - 1 week ago
$AQST $SPRY High interest rate will hurt biotech sector. I think we will see SPRY under $10 soon.
Mattbean
Posted - 1 week ago
$SPRY Couldn't help it. Had to buy a few hundred more at $10.75. Now waiting for $9 handle to buy a larger chunk.
Mattbean
Posted - 1 week ago
$SPRY Love it. $10 handle but I'm going to be greedy and wait for it to drop some more :)
SHADOWxGAINZ
Posted - 1 week ago
$SPRY the price action today is interesting to me
Mattbean
Posted - 1 week ago
$SPRY Excited! Getting close to that $10 handle so I can buy some more! :) Keep going baby!
RoyMunson69
Posted - 1 week ago
$SPRY How we doin?
Mattbean
Posted - 1 week ago
$SPRY still not down enough. waiting for the $10 handle to buy more.
RoyMunson69
Posted - 1 week ago
$SPRY Some say I am a genie
BlackMyth
Posted - 1 week ago
$SPRY $AQST I think Big Pharm will buy out these 2 companies because BP need a lot of fertilizer for their lawn. lol
UncleRicoQB1
Posted - 1 week ago
$AQST what a fuking disaster. Now it won't even track with $IWM $XBI or $SPRY.
Mattbean
Posted - 1 week ago
$SPRY Good :)
RoyMunson69
Posted - 1 week ago
$SPRY Your wish will be granted
Mattbean
Posted - 1 week ago
$SPRY Please go lower this week.
RoyMunson69
Posted - 1 week ago
$SPRY 250m peak sales tops. 30% of analyst pumper estimates
h3ster
Posted - 1 week ago
$AQST The chart for AQST has followed SPRY almost exactly for the last year. The only way it separates is with continued execution for Anaphylm and continued low revenues for $SPRY.
prodigy81
Posted - 1 week ago
@Falcones $SPRY is worse than $AQST I think. The C-suite is selling in $SPRY
Fireflyaway
Posted - 1 week ago
$SPRY More insider selling WTF!!! 😂 $5 coming
Fireflyaway
Posted - 1 week ago
$SPRY Insiders still selling this 💩until $5
Falcones
Posted - 1 week ago
$AQST Can’t be coincidence that $SPRY is also falling last couple of days. What’s going on 🧐.